Boehringer Ingelheim Pharma Gmbh Co & ... vs Centurion Remedies Private Limited & ... on 26 August, 2022
years.
11. The plaintiffs claims that the medicinal products 'Linagliptin Tablet'
and 'Linagliptin + Metformin Hydrochloride Tablets', covered by the
subject patent ... favour.
16. Accordingly, the defendants are restrained from manufacturing
'Linagliptin' in any form whatsoever including 'Linagliptin API',
'Linagliptin' formulation